Carol Karp
Consejero General en PROTHENA CORPORATION PLC .
Fortuna: - $ al 30/04/2024
Cargos activos de Carol Karp
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Consejero General | 15/12/2016 | - |
| Rochester Christian University | Director/Miembro de la Junta | - | - |
Historial de carrera de Carol Karp
Antiguos cargos conocidos de Carol Karp.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ESPERION THERAPEUTICS, INC. | Oficial de Cumplimiento | 01/01/2013 | 01/01/2014 |
| Consejero General | 01/01/2013 | 01/01/2014 | |
| Janssen Alzheimer Immunotherapy | Consejero General | 01/01/2010 | 01/01/2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Consejero General | - | 02/05/2011 |
| VIVUS, INC. | Corporate Officer/Principal | - | - |
| Powderject Technologies BV | Director Técnico/Científico/I+D | - | - |
Formación de Carol Karp.
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Países Bajos | 2 |
| Irlanda | 2 |
Operativa
| General Counsel | 4 |
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Empresas privadas | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
| Janssen Alzheimer Immunotherapy |
- Bolsa de valores
- Insiders
- Carol Karp
- Experiencia
